GLP1

While some may stand to gain access to the drugs under these categories, another factor in assessing the deal’s impact is that millions are expected to lose federal …

Key Takeaways Medicare and Medicaid will cover drugs used for weight loss for the first time, offering Wegovy, Zepbound, Monjauro, and Ozempic for $50 a month co-pays. The …

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every …

Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price …

For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National Health and Well-Being Index has found …